Published in Cancer Weekly, March 30th, 1998
The agreement enables Longport's scanner technology to be utilized for the first time ever, in a breast cancer environment.
The initial goal of this joint venture is to customize the healing process of post mastectomy patients providing them an opportunity to return to a normal lifestyle sooner than currently possible.
This marks the first step in the long-term commitment by Longport, Inc. to support and promote breast wellness.
Longport, Inc. also announced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-03-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.